{"id":"https://openalex.org/W4282980565","doi":"https://doi.org/10.1158/1538-7445.am2022-1886","title":"Abstract 1886: Targeting oral squamous cell carcinoma tumor microenvironment through simultaneous modulation of pattern recognition receptors and angiogenic factors using a synthetic polymer-based drug","display_name":"Abstract 1886: Targeting oral squamous cell carcinoma tumor microenvironment through simultaneous modulation of pattern recognition receptors and angiogenic factors using a synthetic polymer-based drug","publication_year":2022,"publication_date":"2022-06-15","ids":{"openalex":"https://openalex.org/W4282980565","doi":"https://doi.org/10.1158/1538-7445.am2022-1886"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2022-1886","doi":"https://doi.org/10.1158/1538-7445.am2022-1886","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2022-1886","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100638475","display_name":"Won Yong Lee","orcid":"https://orcid.org/0000-0001-7915-1829","observed_orcids":["https://orcid.org/0000-0001-7915-1829"]},"institutions":[{"id":"https://openalex.org/I4210157291","display_name":"GlycoMira Therapeutics (United States)","ror":"https://ror.org/04t28w240","country_code":"US","type":"company","lineage":["https://openalex.org/I4210157291"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Won Yong Lee","raw_affiliation_strings":["1GlycoMira Therapeutics, Inc., Salt Lake City, UT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1GlycoMira Therapeutics, Inc., Salt Lake City, UT;","institution_ids":["https://openalex.org/I4210157291"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064224860","display_name":"Frida Ponthan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118714","display_name":"Epistem (United Kingdom)","ror":"https://ror.org/02a8kfj58","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210118714"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Frida Ponthan","raw_affiliation_strings":["2Epistem Limited, Manchester, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Epistem Limited, Manchester, United Kingdom;","institution_ids":["https://openalex.org/I4210118714"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5028274750","display_name":"Stephen T. Sonis","orcid":"https://orcid.org/0000-0001-6480-2625","observed_orcids":["https://orcid.org/0000-0001-6480-2625"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephen T. Sonis","raw_affiliation_strings":["3Biomodels LLC, Waltham, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Biomodels LLC, Waltham, MA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"82","issue":"12_Supplement","first_page":"1886","last_page":"1886"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","score":0.5609999895095825,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","score":0.5609999895095825,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10371","display_name":"Immune Response and Inflammation","score":0.20640000700950623,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.04780000075697899,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/oral-squamous-cell-carcinoma","display_name":"oral squamous cell carcinoma","score":0.9879999756813049},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.9210000038146973},{"id":"https://openalex.org/keywords/pattern-recognition-receptors","display_name":"pattern recognition receptors","score":0.8659999966621399},{"id":"https://openalex.org/keywords/tlr2","display_name":"TLR2","score":0.796999990940094},{"id":"https://openalex.org/keywords/nlrp3-inflammasome","display_name":"NLRP3 inflammasome","score":0.9860000014305115},{"id":"https://openalex.org/keywords/anti-inflammatory-therapy","display_name":"anti-inflammatory therapy","score":0.7369999885559082},{"id":"https://openalex.org/keywords/angiogenesis-inhibition","display_name":"angiogenesis inhibition","score":0.7730000019073486},{"id":"https://openalex.org/keywords/vascular-endothelial-growth-factor","display_name":"vascular endothelial growth factor","score":0.8370000123977661},{"id":"https://openalex.org/keywords/cxcl12","display_name":"CXCL12","score":0.9629999995231628},{"id":"https://openalex.org/keywords/fgf2","display_name":"FGF2","score":0.9620000123977661},{"id":"https://openalex.org/keywords/combined-radiotherapy","display_name":"combined radiotherapy","score":0.6499999761581421},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.6869999766349792},{"id":"https://openalex.org/keywords/fadu-cells","display_name":"FaDu cells","score":0.6449999809265137},{"id":"https://openalex.org/keywords/immunosuppressive-tumor-microenvironment","display_name":"immunosuppressive tumor microenvironment","score":0.6700000166893005}],"concepts":[{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.7302995920181274},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6505478620529175},{"id":"https://openalex.org/C2781236682","wikidata":"https://www.wikidata.org/wiki/Q410015","display_name":"TLR2","level":4,"score":0.5876149535179138},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5803850293159485},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4641009569168091},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.4520643949508667},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4398013949394226},{"id":"https://openalex.org/C2779256057","wikidata":"https://www.wikidata.org/wiki/Q16909647","display_name":"Tumor progression","level":3,"score":0.43080341815948486},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4298367202281952},{"id":"https://openalex.org/C13373296","wikidata":"https://www.wikidata.org/wiki/Q421866","display_name":"Chemokine","level":3,"score":0.423258513212204},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.35356903076171875},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.28528445959091187},{"id":"https://openalex.org/C136449434","wikidata":"https://www.wikidata.org/wiki/Q428253","display_name":"Innate immune system","level":3,"score":0.21806451678276062}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2022-1886","doi":"https://doi.org/10.1158/1538-7445.am2022-1886","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2022-1886","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4389885304","https://openalex.org/W2560872734","https://openalex.org/W2061247109","https://openalex.org/W7148759308","https://openalex.org/W4200438096","https://openalex.org/W4313359893","https://openalex.org/W2516303237","https://openalex.org/W4293662971","https://openalex.org/W4281767068","https://openalex.org/W2980275245"],"abstract_inverted_index":{"Abstract":[0],"Squamous":[1],"cell":[2,203,330,347],"carcinomas":[3],"(SCCs)":[4],"are":[5,19,82],"the":[6,12,28,32,51,62,71,126,206,245,253,267,275,370],"dominant":[7],"form":[8],"of":[9,11,34,46,54,65,99,354,369],"cancers":[10,36],"upper":[13],"aerodigestive":[14],"tract.":[15],"Main":[16],"risk":[17],"factors":[18,360],"smoking":[20],"and":[21,77,102,138,157,170,321,358],"human":[22,327],"papilloma":[23],"virus":[24],"(HPV)":[25],"infection.":[26],"Despite":[27],"HPV":[29],"vaccination":[30],"efforts,":[31],"number":[33],"oropharyngeal":[35],"(OSCCs)":[37],"has":[38,93,315],"been":[39,94],"steadily":[40],"increasing":[41],"especially":[42],"in":[43,125,134,205,239],"males.":[44],"Standard":[45],"care":[47],"primarily":[48],"focuses":[49],"on":[50],"surgical":[52],"removal":[53],"cancerous":[55],"tissues":[56],"followed":[57],"by":[58,184],"chemoradiation":[59],"therapy.":[60],"However,":[61],"recurrence":[63],"rate":[64],"OSCCs":[66],"remains":[67],"fairly":[68],"high":[69],"as":[70,96,104,114,155,188,190],"tumor":[72,91,128,141,182,204,259,308,349],"frequently":[73],"develops":[74],"therapy":[75,100,270],"resistance":[76,101],"more":[78],"effective":[79],"therapeutic":[80,107],"regimens":[81],"needed.":[83],"The":[84],"chronic":[85],"inflammatory":[86],"state":[87],"yet":[88],"paradoxical":[89],"immunosuppressive":[90],"microenvironment":[92,350],"regarded":[95],"a":[97,105,145,316,362],"cause":[98],"suggested":[103],"potential":[106,317],"target.":[108],"Pattern":[109],"recognition":[110,356],"receptors":[111,116,357],"(PRRs)":[112],"such":[113,154],"toll-like":[115],"(TLRs)":[117],"contribute":[118],"to":[119,130,179,249,274,318],"pro-inflammatory":[120,140,187],"tissue":[121],"responses.":[122],"TLR2":[123,156],"present":[124],"OSCC":[127,181,320],"appears":[129],"play":[131],"important":[132],"roles":[133],"regulating":[135],"immune":[136],"responses":[137],"promoting":[139],"microenvironment.":[142],"GM-1111":[143,162,175,215,231,281,314],"is":[144],"synthetic":[146,363],"glycosaminoglycan-based":[147],"anti-inflammatory":[148],"molecule":[149],"that":[150,174,313],"potently":[151],"inhibits":[152,163],"PRRs":[153],"NLRP3":[158],"inflammasome.":[159],"In":[160],"addition,":[161],"multiple":[164],"angiogenic":[165,191,359],"molecules":[166],"-":[167],"CXCL12,":[168],"VEGF,":[169],"FGF2.":[171],"We":[172],"hypothesized":[173],"might":[176],"be":[177],"able":[178],"reduce":[180,319],"growth":[183],"simultaneously":[185],"disrupting":[186],"well":[189],"signaling.":[192],"To":[193],"test":[194],"this":[195],"hypothesis,":[196],"male":[197],"CD1":[198],"nude":[199],"mice":[200],"bearing":[201],"FaDu":[202],"back":[207],"were":[208],"treated":[209,282],"with":[210,222,232],"either":[211],"(1)":[212,278],"vehicle,":[213],"(2)":[214],"(30":[216],"mg/kg,":[217],"q.d.,":[218],"s.c.),":[219],"(3)":[220],"vehicle":[221,276],"irradiation":[223,233],"(2":[224],"Gy/day":[225],"x":[226],"5":[227,264],"days),":[228],"or":[229,257],"(4)":[230],"17":[234],"days.":[235,255],"Established":[236],"tumors":[237],"grew":[238],"two":[240],"phases":[241],"from":[242],"slow":[243],"for":[244,373],"initial":[246],"7":[247],"days":[248,265],"fast":[250],"growths":[251],"during":[252],"remaining":[254],"Irradiation-":[256],"drug-induced":[258],"regression":[260],"was":[261],"observable":[262],"about":[263],"after":[266],"last":[268],"radiation":[269],"(day":[271],"10).":[272],"Compared":[273],"only":[277],"treatment":[279],"group,":[280],"animals":[283],"(groups":[284],"1":[285,292,299],"vs.":[286,293,300],"2:":[287],"p":[288,295,302],"=":[289],"0.0032;":[290],"groups":[291,298],"3:":[294],"<":[296,303],"0.0001;":[297],"4:":[301],"0.0001)":[304],"demonstrated":[305],"significantly":[306],"reduced":[307],"growth.":[309],"These":[310],"results":[311],"suggest":[312],"further":[322],"confirm":[323],"our":[324],"previous":[325],"orthotopic":[326],"tongue":[328],"SCC-25":[329],"xenograft":[331],"study":[332],"data.":[333],"Citation":[334],"Format:":[335],"Won":[336],"Yong":[337],"Lee,":[338],"Frida":[339],"Ponthan,":[340],"Stephen":[341],"T.":[342],"Sonis.":[343],"Targeting":[344],"oral":[345],"squamous":[346],"carcinoma":[348],"through":[351],"simultaneous":[352],"modulation":[353],"pattern":[355],"using":[361],"polymer-based":[364],"drug":[365],"[abstract].":[366],"In:":[367],"Proceedings":[368],"American":[371],"Association":[372],"Cancer":[374,385],"Research":[375],"Annual":[376],"Meeting":[377],"2022;":[378],"2022":[379],"Apr":[380],"8-13.":[381],"Philadelphia":[382],"(PA):":[383],"AACR;":[384],"Res":[386],"2022;82(12_Suppl):Abstract":[387],"nr":[388],"1886.":[389]},"counts_by_year":[],"updated_date":"2026-09-23T05:00:35.095934","created_date":"2022-06-17T00:00:00"}